FERRETTI (09638): KKCG Maritime has received a valid acceptance offer for 2000 shares.
Ferrari (09638) announced that as of 5:30 pm (Central European Time) on the date of this announcement, KKCG Maritime has received valid acceptance of 2000 shares (representing approximately 0.000591% of the issued shares as of the date of this announcement and approximately 0.003836% of the maximum number of shares (i.e. 52,132,900 shares)).
FERRETTI (09638) announcement as of 5:30 pm Central European Time on the date of this announcement (00:30 am Hong Kong time on March 19, 2026):
(a) As of the date of this announcement, KKCG Maritime has received acceptances for 2000 shares (representing approximately 0.000591% of the total issued shares up to the date of this announcement and approximately 0.003836% of the maximum number of shares (i.e. 5213.29 million shares));
(b) During the acceptance period, KKCG Maritime has received a total of 2000 shares (representing approximately 0.000591% of the total issued shares up to the date of this announcement and approximately 0.003836% of the maximum number of shares) of valid acceptance offers.
Related Articles

Pre-market report on A-shares | Conflict escalation combined with hawkish stance of the Fed! The "triple kill" of US stocks, bonds, and gold; chemical giant announces price increases again.

Brokerage morning meeting highlights | Coal production drops, demand increases, the narrative is clear, and the space is wide open.

ABBISKO-B(02256): FGFR2/3 inhibitor ABSK061 has been granted orphan drug designation by the FDA for the treatment of achondroplasia.
Pre-market report on A-shares | Conflict escalation combined with hawkish stance of the Fed! The "triple kill" of US stocks, bonds, and gold; chemical giant announces price increases again.

Brokerage morning meeting highlights | Coal production drops, demand increases, the narrative is clear, and the space is wide open.

ABBISKO-B(02256): FGFR2/3 inhibitor ABSK061 has been granted orphan drug designation by the FDA for the treatment of achondroplasia.

RECOMMEND

European Carmakers Embrace China: Under Technology And Cost Pressure, Stellantis And Mercedes Seek Partnerships With Chinese Automakers
17/03/2026

HKEX Listing Mechanism Reform Revisited: How To Balance New Favorites And Established Names
17/03/2026

International Oil Prices Plunge Boosts U.S. Stocks; Morgan Stanley Chief Says Market Correction Nearing End
17/03/2026


